[Two breakthroughs in the treatment of type 2 diabetes. Both the receptor agonist and enzyme inhibitors now available in the clinic]
العنوان: | [Two breakthroughs in the treatment of type 2 diabetes. Both the receptor agonist and enzyme inhibitors now available in the clinic] |
---|---|
المؤلفون: | Bo, Ahrén |
المصدر: | Lakartidningen. 104(49-50) |
سنة النشر: | 2008 |
مصطلحات موضوعية: | Vildagliptin, Dipeptidyl-Peptidase IV Inhibitors, Pyrrolidines, Venoms, Dipeptidyl Peptidase 4, Adamantane, Glucagon-Like Peptide-1 Receptor, Treatment Outcome, Diabetes Mellitus, Type 2, Glucagon-Like Peptide 1, Nitriles, Receptors, Glucagon, Animals, Exenatide, Humans, Hypoglycemic Agents, Drug Therapy, Combination, Enzyme Inhibitors, Peptides |
تدمد: | 0023-7205 |
الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=pmid________::32008cb95a8f05199cab2c0f65590856Test https://pubmed.ncbi.nlm.nih.gov/18376713Test |
رقم الانضمام: | edsair.pmid..........32008cb95a8f05199cab2c0f65590856 |
قاعدة البيانات: | OpenAIRE |